Kaufman, Jean Marc

Orwoll, Eric S.

Szulc, Pawel

English

PubMed

Pawel Szulc

Jean Marc Kaufman

Eric S. Orwoll

Crossref

Journal of Osteoporosis

Osteoporosis in Men

Directory of Open Access Journals

3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan,”

A .T r o m b e t t i ,F .H e r r m a n n ,P .H o

A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: eﬀects on bone mineral density and bone markers,”

A reference standard for the description of osteoporosis,”

Alendronate for the treatment of osteoporosis in men,”

Alendronate treatment of established primary osteoporosis in men: 3-Year results of a prospective, comparative, two-arm study,”

ams¨ a, “BMD T-score discriminates trochanteric fractures from unfractured controls, whereas geometry discriminates cervical fracture cases from unfractured controls of similar

Anti-fracture eﬃcacy of risedronic acid in men: a meta-analysis of randomized controlled trials,”

Antifracture eﬃcacy and safety of once-yearly zoledronic acid 5 mg in men with osteoporosis:aprospective,randomized,controlledtrial,”Osteoporosis International,

Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham heart study,”

B.AbrahamsenandP.Vestergaard,“Decliningincidenceofhip fractures and the extent of use of anti-osteoporotic therapy

Biochemical markers of bone turnover, hip bone loss, and fracture in older men:

Change in hip fracture incidence over the last 6 years in France,”

Cross-sectional analysis of the association between fragility fractures and bone microarchitecture in older men: the STRAMBO study,”

Delmas,“Bonemineraldensitypredictsosteoporoticfractures in elderly men:

Development of a nomogram for individualizing hip fracture risk in men and women,”

Distribution and rate of clinical fractures in older men without osteoporosis: the osteoporotic fractures in men (MrOS) study,”

E.S.Orwoll,P.D.Miller,J.D.Adachietal.,“Eﬃcacyandsafety of a once-yearly i.v. infusion of zoledronic acid 5mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis:arandomized,multicenter,double-blind,activecontrolled study,”

Eﬃcacy and safety of monthly ibandronate in men with low bone density,”

Ensrud et al., “Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men,”

Evidence from data searches and life-table analyses for gender-related diﬀerences in absolute risk of hip fracture after Colles’ or spine fracture: Colles’ fracture as an early and sensitive marker of skeletal fragility in white men,”

Excess mortality or institutionalization afterhipfracture:menareatgreaterriskthanwomen,”Journal

Finite element analysis of the proximal femur and hip fracture risk in older men,”

for the ISCD Position Development Conference, “Diagnosis of osteoporosis in men, premenopausal women, and children,”

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study,”

Fracture prediction and calibration of a Canadian FRAX tool: a populationbased report from

High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective

Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age:

J.A.Baron,M.Karagas,J.Barrettetal.,“Basicepidemiologyof fractures of the upper and lower limb among americans over 65 years of age,”

Litwack Harrison et al., “Type I collagen isomerization (Alpha/Beta CTX Ratio) and risk of clinical vertebral fracture in men: a prospective study,” http://www.asbmr.org/itinerary/presentationdetail.aspx?id=

M.R.Smith,B.Egerdie,N.H.Torizetal.,“Denosumabinmen receiving androgen-deprivation therapy for prostate cancer,” The New England

Mellstr¨ om et al., “Serum ﬁbroblast growth factor-23 (FGF-23) and fracture risk in elderly men,”

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women,”

Older men with low serum estradiol and high serum SHBG have an increased risk of fractures,”

Older men with low serum IGF-1 have an increased risk of incident fractures:

Once-weekly risedronate in men with osteoporosis: results of a 2-Year, placebo-controlled, double-blind, multicenter study,”

Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing, but under-recognized problem,”

Plasma 25-hydroxyvitamin D levels and fracture risk in a communitybased cohort of elderly men in

Prediction of new clinical vertebral fractures in elderly men using ﬁnite element analysis of CT scans,”

Prevalent fractures are related to cortical bone geometry in young healthy men at age of peak bone mass,”

Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram,”OsteoporosisInternational,vol.21,no.5,pp.863– 871,

Proximal femoral structure and the prediction of hip fracture in men:4 Journal of Osteoporosis a large prospective study using QCT,”

Quantitative ultrasound predicts hip and non-spine fracture in men:

Rapin,andR.Rizzoli,“Incidenceofhipfractureovera10-year period (1991–2000): reversal of a secular trend,”

Recent trends in the incidence and lifetime risk of hip fracture in Tottori,

Risk factors for peripheral fractures vary by age in older men-the prospective

Teriparatide eﬀects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy,”

testosterone, and the risk for hip fractures

The eﬀect of teriparatide[humanparathyroidhormone(1–34)]therapyon bone density in men with osteoporosis,”

The eﬀects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk

The inﬂuence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam study,”

The near absence of osteoporosis treatment in older men with fractures,”

The outcomes of patients newly admitted to nursing homes after hip fracture,”

Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer,”

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer,”

Trend of hip fracture incidence in Germany 1995–2004: a population-based study,”

Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy,”

Undertreatment of osteoporosis in men with hip fracture,”

Undertreatment with anti-osteoporotic drugs after hospitalization for fracture,”

W.D.Leslie,S.O’Donnell,S.Jeanetal.,“Trendsinhipfracture rates in Canada,”

width of tubular bones is associated with increased risk of fragility fracture

http://downloads.hindawi.com/journals/jos/2012/675984.pdf

Osteoporosis in Men

Abstract

Similar works

Full text

Available Versions

Crossref

Directory of Open Access Journals